Pfizer-BioNTech AstraZeneca (Covishield)

Post on 12-Feb-2022

3 views 0 download

Transcript of Pfizer-BioNTech AstraZeneca (Covishield)

The National Medical Taskforce for Combatting the Coronavirus

Those who qualify for the booster dose can choose to take the Pfizer-Biontech vaccination or take the same type of vaccination that they took for their first

and second doses as a booster dose.

for those aged 60 and above

and the immunocompromised

21

Pfizer-BioNTech AstraZeneca (Covishield)

Approves a booster vaccination for those who have been fully vaccinated

for six months with the

The green vaccination shield will return after receiving the booster dose

21

The vaccination status of individuals eligible for a booster shot will change on the BeAware Bahrain application from the Green Shield to the Yellow Shield until they opt to receive a booster shot.

Starting from 1 October 2021

The opening of registration for the booster dose will be announced in due course